Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Riedmann

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|July 3, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|March 5, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|October 3, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|September 30, 2014
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|November 7, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 27, 2013
Human Vaccines & Immunotherapeutics. Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|May 3, 2014
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 24, 2012
Cancer vaccine development represents a particularly interesting and active fieldRonald Ellis, Eva M Riedmann
Human Vaccines|March 19, 2011
Vaccine research and developmentRonald W Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|February 28, 2013
Letter from the editor: field of vaccines and immunotherapeuticsRonald W Ellis, Eva M Riedmann
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|July 3, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|March 5, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|October 3, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|September 30, 2014
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|November 7, 2013
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 27, 2013
Human Vaccines & Immunotherapeutics. Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|May 3, 2014
Letter from the editorRonald Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 24, 2012
Cancer vaccine development represents a particularly interesting and active fieldRonald Ellis, Eva M Riedmann
Human Vaccines|March 19, 2011
Vaccine research and developmentRonald W Ellis, Eva M Riedmann
Human Vaccines & Immunotherapeutics|February 28, 2013
Letter from the editor: field of vaccines and immunotherapeuticsRonald W Ellis, Eva M Riedmann
Pageof 10